Literature DB >> 7813323

The spectrum of pulmonary embolism. Clinicopathologic correlations.

M Morpurgo1, C Schmid.   

Abstract

Pulmonary embolism (PE) is still underdiagnosed even in hospitalized patients. In our recent experience, out of 92 postmortem cases of massive or submassive PE, only 28% were diagnosed before death, whereas the false-positives accounted only for 3% of cases. Similar conclusions have been drawn from large-scale autopsy studies performed in Norway and in the United States. The most important causes of an incorrect diagnosis are failure to suspect PE, and the protean nature of the disease. Remarkable differences actually exist concerning the point of origin and the final localization, as well as the size and age of thromboemboli, the presence or absence of pulmonary infarction, and the underlying pathology. Often a fatal embolus is relatively small but hardly tolerated because of the underlying cardiopulmonary situation. Attention should be called to the frequent autopsy finding of multiple PEs and pulmonary infarctions of apparently different age. This finding is important since it indicates that these patients suffered successive embolizations and the eventual death might have been prevented if an early diagnosis had been made.

Entities:  

Mesh:

Year:  1995        PMID: 7813323     DOI: 10.1378/chest.107.1_supplement.18s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

1.  Unsuspected pulmonary thromboemboli: a continuing clinical challenge.

Authors:  Herbert L Fred
Journal:  Tex Heart Inst J       Date:  2013

2.  Comparison of isoflurane and α-chloralose in an anesthetized swine model of acute pulmonary embolism producing right ventricular dysfunction.

Authors:  Daren M Beam; Evandro M Neto-Neves; William B Stubblefield; Nathan J Alves; Johnathan D Tune; Jeffrey A Kline
Journal:  Comp Med       Date:  2015-02       Impact factor: 0.982

Review 3.  [Errors and risks in perioperative thrombolysis therapy].

Authors:  F Spöhr; B W Böttiger; A Walther
Journal:  Anaesthesist       Date:  2005-05       Impact factor: 1.041

4.  Real-time MR with TrueFISP for the detection of acute pulmonary embolism: initial clinical experience.

Authors:  Alexander Kluge; Clemens Müller; Jochen Hansel; Tibo Gerriets; Georg Bachmann
Journal:  Eur Radiol       Date:  2003-12-05       Impact factor: 5.315

5.  [Therapeutic approaches to acute pulmonary embolism].

Authors:  A Reissig; C Kroegel
Journal:  Internist (Berl)       Date:  2004-05       Impact factor: 0.743

Review 6.  Gas exchange and pulmonary hypertension following acute pulmonary thromboembolism: has the emperor got some new clothes yet?

Authors:  John Y C Tsang; James C Hogg
Journal:  Pulm Circ       Date:  2014-06       Impact factor: 3.017

7.  Postmortem demonstration of the source of pulmonary thromboembolism: the importance of the autopsy.

Authors:  Gina Elhammady; Andrew T Schubeck; Vicky El-Najjar; Morton J Robinson
Journal:  Case Rep Vasc Med       Date:  2011-10-18

8.  Thrombolysis treatment for submassive pulmonary thromboembolism in patients with cancer: a safe therapeutic tool.

Authors:  Juliano Pinheiro de Almeida; Filomena Regina Barbosa Gomes Galas; Roberto Kalil Filho; Rosana Ely Nakamura; Daniele Nagaoka; Ludhmila Abrahão Hajjar
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

9.  Relationship Between CHA2DS2-VASc Score and Right Ventricular Dysfunction in Patients With Acute Pulmonary Thromboembolism.

Authors:  Murat Gök; Alparslan Kurtul; Murat Harman; Meryem Kara; Muhammed Süleymanoglu; Ender Ornek
Journal:  Clin Appl Thromb Hemost       Date:  2018-07-11       Impact factor: 2.389

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.